vs

Side-by-side financial comparison of Evolent Health, Inc. (EVH) and USA Compression Partners, LP (USAC). Click either name above to swap in a different company.

Evolent Health, Inc. is the larger business by last-quarter revenue ($468.7M vs $252.5M, roughly 1.9× USA Compression Partners, LP). USA Compression Partners, LP runs the higher net margin — 11.0% vs -91.6%, a 102.5% gap on every dollar of revenue. On growth, USA Compression Partners, LP posted the faster year-over-year revenue change (2.7% vs -27.5%). Over the past eight quarters, USA Compression Partners, LP's revenue compounded faster (4.9% CAGR vs -14.4%).

Magellan Health Inc., is an American for-profit managed health care company and subsidiary of Centene that focuses on special populations and other specialty areas of healthcare. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. It ranked 390 on the Fortune 500 in 2021.

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

EVH vs USAC — Head-to-Head

Bigger by revenue
EVH
EVH
1.9× larger
EVH
$468.7M
$252.5M
USAC
Growing faster (revenue YoY)
USAC
USAC
+30.2% gap
USAC
2.7%
-27.5%
EVH
Higher net margin
USAC
USAC
102.5% more per $
USAC
11.0%
-91.6%
EVH
Faster 2-yr revenue CAGR
USAC
USAC
Annualised
USAC
4.9%
-14.4%
EVH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EVH
EVH
USAC
USAC
Revenue
$468.7M
$252.5M
Net Profit
$-429.1M
$27.8M
Gross Margin
20.7%
Operating Margin
-87.1%
30.3%
Net Margin
-91.6%
11.0%
Revenue YoY
-27.5%
2.7%
Net Profit YoY
-1782.0%
9.1%
EPS (diluted)
$-3.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EVH
EVH
USAC
USAC
Q4 25
$468.7M
$252.5M
Q3 25
$479.5M
$250.3M
Q2 25
$444.3M
$250.1M
Q1 25
$483.6M
$245.2M
Q4 24
$646.5M
$245.9M
Q3 24
$621.4M
$240.0M
Q2 24
$647.1M
$235.3M
Q1 24
$639.7M
$229.3M
Net Profit
EVH
EVH
USAC
USAC
Q4 25
$-429.1M
$27.8M
Q3 25
$-20.9M
$34.5M
Q2 25
$-19.9M
$28.6M
Q1 25
$-64.6M
$20.5M
Q4 24
$-22.8M
$25.4M
Q3 24
$-23.1M
$19.3M
Q2 24
$1.6M
$31.2M
Q1 24
$-17.3M
$23.6M
Gross Margin
EVH
EVH
USAC
USAC
Q4 25
20.7%
Q3 25
20.8%
Q2 25
22.6%
Q1 25
21.2%
Q4 24
11.7%
Q3 24
13.0%
Q2 24
16.5%
Q1 24
16.3%
Operating Margin
EVH
EVH
USAC
USAC
Q4 25
-87.1%
30.3%
Q3 25
0.2%
33.5%
Q2 25
-0.3%
30.6%
Q1 25
-0.3%
28.3%
Q4 24
-2.9%
30.3%
Q3 24
-2.6%
31.5%
Q2 24
1.2%
32.9%
Q1 24
-2.1%
29.2%
Net Margin
EVH
EVH
USAC
USAC
Q4 25
-91.6%
11.0%
Q3 25
-4.4%
13.8%
Q2 25
-4.5%
11.4%
Q1 25
-13.4%
8.4%
Q4 24
-3.5%
10.3%
Q3 24
-3.7%
8.1%
Q2 24
0.2%
13.3%
Q1 24
-2.7%
10.3%
EPS (diluted)
EVH
EVH
USAC
USAC
Q4 25
$-3.76
Q3 25
$-0.24
Q2 25
$-0.44
Q1 25
$-0.63
Q4 24
$-0.26
Q3 24
$-0.27
Q2 24
$-0.06
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EVH
EVH
USAC
USAC
Cash + ST InvestmentsLiquidity on hand
$151.9M
$8.6M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$415.2M
Total Assets
$1.9B
$2.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EVH
EVH
USAC
USAC
Q4 25
$151.9M
$8.6M
Q3 25
$116.7M
Q2 25
$151.0M
$2.0K
Q1 25
$246.5M
$2.0K
Q4 24
$104.2M
$14.0K
Q3 24
$96.6M
$79.0K
Q2 24
$101.3M
$9.0K
Q1 24
$165.1M
$8.0K
Total Debt
EVH
EVH
USAC
USAC
Q4 25
$2.5B
Q3 25
$2.5B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.5B
Q2 24
$2.5B
Q1 24
$2.5B
Stockholders' Equity
EVH
EVH
USAC
USAC
Q4 25
$415.2M
Q3 25
$842.2M
Q2 25
$896.0M
Q1 25
$935.5M
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.1B
Q1 24
$1.0B
Total Assets
EVH
EVH
USAC
USAC
Q4 25
$1.9B
$2.6B
Q3 25
$2.5B
$2.7B
Q2 25
$2.5B
$2.7B
Q1 25
$2.7B
$2.7B
Q4 24
$2.5B
$2.7B
Q3 24
$2.5B
$2.8B
Q2 24
$2.5B
$2.8B
Q1 24
$2.6B
$2.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EVH
EVH
USAC
USAC
Operating Cash FlowLast quarter
$48.8M
$139.5M
Free Cash FlowOCF − Capex
$87.7M
FCF MarginFCF / Revenue
34.8%
Capex IntensityCapex / Revenue
20.5%
Cash ConversionOCF / Net Profit
5.02×
TTM Free Cash FlowTrailing 4 quarters
$277.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EVH
EVH
USAC
USAC
Q4 25
$48.8M
$139.5M
Q3 25
$15.8M
$75.9M
Q2 25
$-30.3M
$124.2M
Q1 25
$4.6M
$54.7M
Q4 24
$-26.2M
$130.2M
Q3 24
$18.7M
$48.5M
Q2 24
$21.4M
$96.7M
Q1 24
$4.9M
$65.9M
Free Cash Flow
EVH
EVH
USAC
USAC
Q4 25
$87.7M
Q3 25
$51.9M
Q2 25
$101.1M
Q1 25
$36.3M
Q4 24
$101.2M
Q3 24
$19.8M
Q2 24
$48.2M
Q1 24
$-32.7M
FCF Margin
EVH
EVH
USAC
USAC
Q4 25
34.8%
Q3 25
20.7%
Q2 25
40.4%
Q1 25
14.8%
Q4 24
41.1%
Q3 24
8.2%
Q2 24
20.5%
Q1 24
-14.3%
Capex Intensity
EVH
EVH
USAC
USAC
Q4 25
20.5%
Q3 25
9.6%
Q2 25
9.3%
Q1 25
7.5%
Q4 24
11.8%
Q3 24
12.0%
Q2 24
20.6%
Q1 24
43.0%
Cash Conversion
EVH
EVH
USAC
USAC
Q4 25
5.02×
Q3 25
2.20×
Q2 25
4.35×
Q1 25
2.66×
Q4 24
5.12×
Q3 24
2.51×
Q2 24
13.42×
3.10×
Q1 24
2.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EVH
EVH

Commercial And Other Customers$147.9M32%
Medicare Customers$111.2M24%
Specialty Technology And Services Suite$95.7M20%
Administrative Service$55.8M12%
Cases$47.7M10%
Related Party$4.5M1%

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

Related Comparisons